Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)

Completed · Phase 2 · Has a placebo group

Conditions studied: Thyroiditis, Autoimmune

In brief

This is a study to evaluate the safety, tolerability, and potential effects of Anatabloc dietary supplementation on antithyroid autoantibodies, thyroid structure, and thyroid function in subjects with autoimmune thyroiditis.

Key facts

Study ID: NCT01551498
Run by: Rock Creek Pharmaceuticals, Inc.
People needed: 165
Starts: 2012-03-01
Expected to finish: 2013-02-01
Last updated by the study team: 2015-11-02

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

adults 18-70 years of age
having positive antibodies against thyroid peroxidase
having sonographic evidence consistent with a diagnosis of Hashimoto's thyroiditis

You may not qualify if…

having evidence of end-stage thyroiditis
being a current smoker or smokeless tobacco user
be taking systemic glucocorticoids, interferon-alpha, anti-CD20 antibody, or anti-CTLA-4 antibody
be taking any medication for treatment of autoimmune thyroiditis other than L-thyroxine or equivalent

Where it is running

Metabolic Research Institute, Inc. — West Palm Beach, Florida, United States
Florida Medical Clinic, P.A. — Zephyrhills, Florida, United States
Robert J. Becker, M.D., LTD — La Grange, Illinois, United States
Associated Endocrinologists, P.C. — West Bloomfield, Michigan, United States
New Jersey Physicians, LLC — Clifton, New Jersey, United States
Texas Diabetes & Endocrinology — Austin, Texas, United States
North Texas Endocrine Center — Dallas, Texas, United States
Research Institute of Dallas — Dallas, Texas, United States
Texas Diabetes & Endocrinology — Round Rock, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.